Ledger.Open graph →
SEC Form D · Amendment · filed January 3, 2019

Elucida Oncology, Inc

Offering
$30.0M
Sold
$28.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Robert A. Ruffolo · New York, NYDirectorRobert A. Essner · New York, NYDirectorTeresa M. Ressel · New York, NYDirectorUlrich T. Wiesner · New York, NYDirectorGeno Germano · New York, NYExec · DirectorMichael T. Smith · New York, NYDirectorIsaac Blech · New York, NYDirectorTim Boris · New York, NYDirectorShaival Shah · New York, NYDirectorVinay J. Patel · Granger, INDirectorEdward J. Graveline · Michigan City, INDirectorJohn J. Stimley · Michigan City, INDirectorAndy Weissman · New York, NYDirectorSherree J. Tipton · Michigan City, INDirectorJason J. Stimley · LaPorte, INExec · DirectorJames J. Paglia · Lantana, TXDirectorTomas Kiselak · Waltham, MADirectorKevin Butler · Grand Cayman, Cayman IslandsDirectorWarren Stoddart · Toronto, Ontario, CanadaExec · DirectorTrinda Blackmore · Grand Cayman, Cayman IslandsDirectorLivio Bisterzo · New York, NYDirectorHugh Thomas · New York, NYDirectorWilliam Gentile · NEW YORK, NYDirectorJohn Ajay · Boca Raton, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗